Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06008626 · ClinicalTrials.gov registry record · NA
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
A NA study of Obstructive Sleep Apnea of Adult, sponsored by Cryosa.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 8
- Study locations
NCT06008626: Recruiting NA study of Obstructive Sleep Apnea of Adult, sponsored by Cryosa.
NCT06008626 is a NA study of Obstructive Sleep Apnea of Adult that is actively recruiting participants, run by Cryosa. The registered enrollment target is 25 participants, below the 522-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (95% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06008626, a NA study of Obstructive Sleep Apnea of Adult, is actively recruiting participants, sponsored by Cryosa.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in patients with moderate to severe OSA. The study will also evaluate the chronic performance of the Cryosa system and collect clinical measures for therapy effectiveness that will be used to demonstrate safety and effectiveness in the next clinical study.
Primary Outcome
Safety will be assessed by evaluating all serious procedure- or device/treatment-related events occurring in the first 90 days post-procedure. Adverse events (AE), both serious and non-serious, related and unrelated, will be collected from all subjects enrolled for the duration of the study.
Conditions Studied
Interventions
- DEVICE Cryosa Procedure
Study Locations (8)
Pennsylvania
- Specialty Physician Associates - Bethlehem
- University of Pennsylvania - Philadelphia
Colorado
- UCHealth University of Colorado - Aurora
Florida
- University of Miami - Miami
Illinois
- Rush University Medical Center - Chicago
New York
- Albany ENT & Allergy Services - Albany
Tennessee
- University of Tennessee Health Sciences Center - Memphis
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-09-12 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06008626 shows while recruiting
NCT06008626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 522-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Obstructive Sleep Apnea of Adult appearing as the primary indexed condition, and to 1 intervention - of which Cryosa Procedure is the first listed.
NCT06008626 lists 8 locations in 7 states (Pennsylvania, Colorado, Florida).
Frequently Asked Questions
What is clinical trial NCT06008626 about?
NCT06008626 is a clinical study titled "Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea". This is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in patients with moderate to severe OSA. The study will also evaluate the chronic performance of the Cryosa...
What is the current status of trial NCT06008626?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-09-12. Estimated completion is 2028-03-31.
What conditions does trial NCT06008626 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea of Adult.
What interventions are being tested in trial NCT06008626?
The interventions under investigation include: Cryosa Procedure (DEVICE).
Who is sponsoring clinical trial NCT06008626?
This trial is sponsored by Cryosa, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06008626 being conducted?
This trial has 8 study locations across Colorado, Florida, Illinois, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea of Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06008626's enrollment target sits among peer trials
25 9th of 8 the lowest of 8 other Obstructive Sleep Apnea of Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea of Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
ThErapy Adherence Management in Veterans
COMPLETED · NA
-
Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study
COMPLETED · NA
-
A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea
RECRUITING
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI